Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Bernhardt

Showing results (151-160 of 224) with videos related to

Pageof 23
Sort By:
The International Journal of Cardiovascular Imaging|October 20, 2010
Myocardial scar extent evaluated by cardiac magnetic resonance imaging in ICD patients: relationship to spontaneous VT during long-term follow-upPeter Bernhardt, Sascha Stiller, Eva Kottmair, et al.
International Journal of Cardiology|October 26, 2010
Cardiac involvement in juvenile overlap-myositis detected by cardiac magnetic resonance imagingMatthias Ponfick, Hans-Jürgen Gdynia, Jan Kassubek, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 24, 2015
Non-contrast-enhanced magnetic resonance angiography is equal to contrast-enhanced multislice computed tomography for correct aortic sizing before transcatheter aortic valve implantationPeter Bernhardt, Christoph Rodewald, Julia Seeger, et al.
Cancers|April 30, 2021
Evaluation of SSTR2 Expression in SI-NETs and Relation to Overall Survival after PRRTAnna-Karin Elf, Viktor Johanson, Ida Marin, et al.
Cancer Biotherapy & Radiopharmaceuticals|February 27, 2008
Comparison of [177Lu-DOTA0,Tyr3]-octreotate and [177Lu-DOTA0,Tyr3]-octreotide for receptor-mediated radiation therapy of the xenografted human midgut carcinoid tumor GOT1Christina Swärd, Peter Bernhardt, Viktor Johanson, et al.
Regulatory Peptides|June 5, 2004
Chromogranin A as a determinant of midgut carcinoid tumour volumeLars Kölby, Peter Bernhardt, Christina Swärd, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 31, 2013
Impact of cell number and microvascular obstruction in patients with bone-marrow derived cell therapy: final results from the randomized, double-blind, placebo controlled intracoronary Stem Cell therapy in patients with Acute Myocardial Infarction (SCAMI) trialJochen Wöhrle, Fabian von Scheidt, Peter Schauwecker, et al.
EJNMMI Research|February 11, 2016
Contribution of Auger/conversion electrons to renal side effects after radionuclide therapy: preclinical comparison of (161)Tb-folate and (177)Lu-folateStephanie Haller, Giovanni Pellegrini, Christiaan Vermeulen, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|October 11, 2023
On-site CT-derived cFFR in patients with suspected coronary artery disease: Feasibility on a 128-row CT scanner in everyday clinical practiceTheresia Baumeister, Christopher Kloth, Stefan Andreas Schmidt, et al.
Annals of the New York Academy of Sciences|November 15, 2006
Can quantification of VMAT and SSTR expression be helpful for planning radionuclide therapy of malignant pheochromocytomas?Lars Kölby, Peter Bernhardt, Viktor Johanson, et al.
Pageof 23

Showing results (151-160 of 224) with videos related to

Sort By:
Pageof 23
The International Journal of Cardiovascular Imaging|October 20, 2010
Myocardial scar extent evaluated by cardiac magnetic resonance imaging in ICD patients: relationship to spontaneous VT during long-term follow-upPeter Bernhardt, Sascha Stiller, Eva Kottmair, et al.
International Journal of Cardiology|October 26, 2010
Cardiac involvement in juvenile overlap-myositis detected by cardiac magnetic resonance imagingMatthias Ponfick, Hans-Jürgen Gdynia, Jan Kassubek, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 24, 2015
Non-contrast-enhanced magnetic resonance angiography is equal to contrast-enhanced multislice computed tomography for correct aortic sizing before transcatheter aortic valve implantationPeter Bernhardt, Christoph Rodewald, Julia Seeger, et al.
Cancers|April 30, 2021
Evaluation of SSTR2 Expression in SI-NETs and Relation to Overall Survival after PRRTAnna-Karin Elf, Viktor Johanson, Ida Marin, et al.
Cancer Biotherapy & Radiopharmaceuticals|February 27, 2008
Comparison of [177Lu-DOTA0,Tyr3]-octreotate and [177Lu-DOTA0,Tyr3]-octreotide for receptor-mediated radiation therapy of the xenografted human midgut carcinoid tumor GOT1Christina Swärd, Peter Bernhardt, Viktor Johanson, et al.
Regulatory Peptides|June 5, 2004
Chromogranin A as a determinant of midgut carcinoid tumour volumeLars Kölby, Peter Bernhardt, Christina Swärd, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 31, 2013
Impact of cell number and microvascular obstruction in patients with bone-marrow derived cell therapy: final results from the randomized, double-blind, placebo controlled intracoronary Stem Cell therapy in patients with Acute Myocardial Infarction (SCAMI) trialJochen Wöhrle, Fabian von Scheidt, Peter Schauwecker, et al.
EJNMMI Research|February 11, 2016
Contribution of Auger/conversion electrons to renal side effects after radionuclide therapy: preclinical comparison of (161)Tb-folate and (177)Lu-folateStephanie Haller, Giovanni Pellegrini, Christiaan Vermeulen, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|October 11, 2023
On-site CT-derived cFFR in patients with suspected coronary artery disease: Feasibility on a 128-row CT scanner in everyday clinical practiceTheresia Baumeister, Christopher Kloth, Stefan Andreas Schmidt, et al.
Annals of the New York Academy of Sciences|November 15, 2006
Can quantification of VMAT and SSTR expression be helpful for planning radionuclide therapy of malignant pheochromocytomas?Lars Kölby, Peter Bernhardt, Viktor Johanson, et al.
Pageof 23